What are the possible causes and recommended evaluation for a rash on the palms and soles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rash on Palms and Soles: Diagnostic Approach

A rash on the palms and soles requires immediate consideration of life-threatening infectious causes—particularly Rocky Mountain Spotted Fever (RMSF) and secondary syphilis—before evaluating for chronic inflammatory conditions like palmoplantar psoriasis or contact dermatitis.

Critical Initial Assessment

Red Flags Requiring Urgent Evaluation

Fever + palmoplantar rash = RMSF until proven otherwise. In RMSF, the rash typically begins 2-4 days after fever onset as small blanching pink macules on ankles, wrists, or forearms, evolving to maculopapules and eventually petechiae that spread to palms and soles by day 5-6 1, 2. Key distinguishing features include:

  • Systemic symptoms: High fever, severe headache, shaking chills, generalized myalgias
  • Timing: Rash appears after fever (unlike many viral exanthems)
  • Progression: Centripetal spread from extremities inward
  • Associated findings: Thrombocytopenia, hyponatremia, elevated transaminases 2

Critical caveat: Up to 20% of RMSF cases never develop a rash, and absence of rash should not exclude the diagnosis in febrile patients with appropriate exposure history 1.

Other Infectious Causes to Consider

The differential for palmoplantar rash with systemic symptoms includes 1:

  • Secondary syphilis (Treponema pallidum)
  • Meningococcemia (Neisseria meningitidis)
  • Rat-bite fever (Streptobacillus moniliformis)
  • Ehrlichiosis (E. chaffeensis)—though palmoplantar involvement is rare
  • Certain enteroviruses (hand-foot-mouth disease in children)

Chronic/Non-Febrile Presentations

Palmoplantar Psoriasis

For chronic, well-demarcated erythematous plaques with silvery scale on palms/soles causing functional impairment, palmoplantar psoriasis is the leading diagnosis. This variant is considered severe regardless of body surface area involved due to its disproportionate impact on quality of life 3, 4.

Clinical features:

  • Erythematous, scaly, fissured hyperkeratotic patches and plaques
  • Significant functional impairment (difficulty walking, using hands)
  • May occur with or without psoriasis elsewhere on the body
  • Can present as pustular variant (palmoplantar pustulosis) 5, 6

Important consideration: In Japan, focal infections (dental, tonsillar) trigger approximately 80% of palmoplantar pustulosis cases, fundamentally altering the treatment algorithm compared to plaque psoriasis 6.

Contact Dermatitis

Suspect allergic contact dermatitis when:

  • History of new product exposure (cosmetics, topical medications, gloves, occupational exposures)
  • Symptoms improve away from work/triggering environment
  • Previously controlled dermatitis becomes refractory to standard treatment 7

Patch testing is mandatory for any chronic or persistent palmoplantar dermatitis, especially when treatment response is poor 7, 8. Studies show patients with palmoplantar psoriasis have higher rates of contact hypersensitivity (25.24%) than those without palm/sole involvement (11%) 8.

Other Chronic Causes

  • Dyshidrotic eczema: Vesicular eruptions on palms/soles
  • Tinea manuum/pedis: Always exclude fungal infection with KOH preparation 9
  • Keratodermas: Hereditary vs. acquired (associated with malignancy, systemic disease, menopause) 10
  • Drug reactions: Including paradoxical psoriasis from TNF-α inhibitors 4

Diagnostic Algorithm

Step 1: Assess for Systemic Illness

  • Fever present? → Consider RMSF, secondary syphilis, meningococcemia
    • Order: CBC with differential, comprehensive metabolic panel, blood smear
    • Look for: Thrombocytopenia, hyponatremia, elevated transaminases, leukopenia 2
    • Start empiric doxycycline immediately if RMSF suspected—do not wait for confirmation

Step 2: Characterize the Rash

  • Vesicular/pustular → Acute triggers (eczematogens, fungi, infections) 11
  • Hyperkeratotic → Chronic/recurrent causes (mechanical irritation, chronic eczema, psoriasis) 11
  • Petechial → Vasculitis, thrombocytopenia, advanced RMSF

Step 3: Obtain Targeted History

  • Occupational exposures: Chemicals, wet work, gloves
  • Product use: New cosmetics, topical medications, cleansers
  • Timing: Relationship to work, weekends, holidays
  • Personal/family history: Atopy, psoriasis, autoimmune disease
  • Tick exposure: Travel to endemic areas, outdoor activities
  • Sexual history: Risk factors for syphilis
  • Focal infections: Dental disease, chronic sinusitis (especially for pustular variants) 6

Step 4: Perform Appropriate Testing

  • KOH preparation: Rule out tinea (positive in 2.9% of "resistant" palmoplantar psoriasis) 8
  • Patch testing: For chronic/refractory cases, especially with occupational exposure 7, 8
  • Skin biopsy: When diagnosis unclear (may reveal psoriasiform spongiotic dermatitis in 5.8% of cases) 8
  • Serologies: RPR/VDRL if secondary syphilis suspected
  • Rickettsial serology: If RMSF suspected (but treat empirically first)

Treatment Considerations

Palmoplantar Psoriasis

Systemic therapy is justified given the severe quality-of-life impact despite limited body surface area 4:

First-line options:

  • Acitretin 25 mg daily: Shown to produce substantial improvement within 2 months 4
  • Topical high-potency corticosteroids (clobetasol) under occlusion
  • Topical PUVA (soak method): 2-3 times weekly 4

Second-line: Methotrexate, cyclosporine, biologics (adalimumab, infliximab) 4

Critical pitfall: Long-term oral PUVA increases squamous cell carcinoma risk; minimize treatment number 4. Topical PUVA to palms/soles carries minimal malignancy risk 4.

Contact Dermatitis

  • Identify and eliminate allergen (most important step)
  • Topical corticosteroids
  • Emollients and barrier protection
  • Consider systemic therapy for severe cases 7

RMSF

  • Doxycycline immediately (even in children and pregnant women)
  • Delay in treatment increases mortality significantly 2

Common Pitfalls

  1. Assuming all palmoplantar rash is benign: Missing RMSF or secondary syphilis can be fatal
  2. Not performing KOH: Secondary fungal infection complicates 2.9% of palmoplantar psoriasis 8
  3. Skipping patch testing: Contact allergy found in 25% of "resistant" palmoplantar psoriasis 8
  4. Ignoring focal infections: Critical trigger in palmoplantar pustulosis, especially in Asian populations 6
  5. Undertreating palmoplantar psoriasis: Small body surface area does not mean mild disease—functional impairment justifies systemic therapy 4

References

Research

Treatment Guidance for Palmoplantar Pustulosis 2022.

The Journal of dermatology, 2026

Research

[Palmoplantar dermatoses in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2021

Research

Acquired palmoplantar keratoderma.

American journal of clinical dermatology, 2007

Research

Palmoplantar reactions.

Dermatology (Basel, Switzerland), 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.